Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors
NCT04765462
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Malignant Solid Tumours
Interventions
BIOLOGICAL:
Allogeneic γδ T cells
Sponsor
Chinese PLA General Hospital